Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.

Development of a novel human triculture model of non-alcoholic fatty liver disease and identification of berberine as ameliorating steatosis, oxidative stress and fibrosis

Open access
Rafiei, Hossein, Yeung, Michelle, Kowalski, Sara, Krystal, Gerald, Elisia, Ingrid · 2023 · Frontiers in Pharmacology

Abstract

Objectives: Non-alcoholic fatty liver disease (NAFLD) and its progression to non-alcoholic steatohepatitis (NASH) and hepatocarcinoma is a serious and growing problem. However, the development of new therapies is severely hindered by a lack of high-throughput assays for drug testing. Methods: We have developed a simple transwell assay comprised of HepG2 hepatocytes, hepatic LX-2 stellate cells, and differentiated THP-1 cells. The cells were incubated with an activating mixture containing the NASH-associated risk factors, glucose, insulin, free fatty acids (FFAs), and lipopolysaccharide (LPS) for 72 h. We compared different combinations of culture conditions to obtain a model system that recapitulates the main features of NAFLD/NASH, i.e., increased steatosis, reactive oxygen species (ROS), secretion of pro-inflammatory cytokines/chemokines, and presence of fibrosis. To confirm the usefulness of the optimized model system, we screened for compounds that inhibit steatosis in the hepatocytes and evaluated the most effective compound in the triculture model system. Results: The activating mixture stimulated HepG2 cells in this triculture to accumulate more fat and produce higher levels of reactive oxygen species (ROS) than HepG2 cells in monocultures. As well, higher levels of inflammatory cytokines and chemokines (IL-8, IL-6, MIP-1α, etc. ) were produced in this triculture compared to monocultures. In addition, in all LX-2 monocultures and cocultures, exposure to the activating mixture increased markers of fibrosis. A major strength of our triculture system is that it makes possible the simultaneous monitoring of 4 main features of NASH, i.e., steatosis, oxidative stress, inflammation and fibrosis. Screening potential modulators that may reduce steatosis in HepG2 cells revealed the protective effects of the isoalkaloid, berberine. Tested using this novel triculture assay, treatment with 5 µM berberine decreased steatosis and ROS in HepG2 hepatocytes, reduced inflammatory cytokine production and inhibited collagen production from LX-2 cells. Conclusion: This simple triculture model recapitulates the main features of NAFLD/NASH and should be useful for high-throughput preclinical drug discovery. In this model, berberine showed promising results in decreasing steatosis and ROS and protection against fibrosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fphar.2023.1234300

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIGURE 1 (A) Experimental design for the coculture models using the transwell system. (B) Representative photomicrographs (original magnification, ×20) of hepatocytes treated with or without the activating mixture and stained with Nile Red and Hoechst are shown. (C) Comparison of the effect of treatment with activating mixture for 72 h on HepG2 cells lipid accumulation in mono, di, and triculture condition. Intracellular lipids after quantification of Nile Red fluorescence using a microplate reader. Nile Red readings were normalized to fluorescence of nucleus-staining dye, Hoechst, which was used to control for cell number and proliferation. (D) Comparison of the effect of treatment with activating mixture for 72 h on ROS generation in HepG2 cells in mono, di, and triculture condition. Intracellular ROS in HepG2 cells after quantification of DCFH-DA fluorescence using a microplate reader. DCFH-DA readings were normalized to Hoechst fluorescence. In the graphs, untreated HepG2 monoculture reading was set at 100% and data are presented as % of the untreated HepG2 monoculture cells. * Significantly different at p < 0.05 with one-way ANOVA. UT, Untreated; T, Treated.
FIGURE 1 (A) Experimental design for the coculture models using the transwell system. (B) Representative photomicrographs (original magnification, ×20) of hepatocytes treated with or without the activating mixture and stained with Nile Red and Hoechst are shown. (C) Comparison of the effect of treatment with activating mixture for 72 h on HepG2 cells lipid accumulation in mono, di, and triculture condition. Intracellular lipids after quantification of Nile Red fluorescence using a microplate reader. Nile Red readings were normalized to fluorescence of nucleus-staining dye, Hoechst, which was used to control for cell number and proliferation. (D) Comparison of the effect of treatment with activating mixture for 72 h on ROS generation in HepG2 cells in mono, di, and triculture condition. Intracellular ROS in HepG2 cells after quantification of DCFH-DA fluorescence using a microplate reader. DCFH-DA readings were normalized to Hoechst fluorescence. In the graphs, untreated HepG2 monoculture reading was set at 100% and data are presented as % of the untreated HepG2 monoculture cells. * Significantly different at p < 0.05 with one-way ANOVA. UT, Untreated; T, Treated.CC BY · PubMed Central
FIGURE 2 Effect of treatment with the activating mixture for 72 h on inflammatory cytokines and chemokines in the culture media collected from mono, di, and triculture conditions. Concentrations of cytokines/chemokines were determined using ELISA and 35-plex Luminex. * Significantly different at p < 0.05. UT, Untreated; T, Treated.
FIGURE 2 Effect of treatment with the activating mixture for 72 h on inflammatory cytokines and chemokines in the culture media collected from mono, di, and triculture conditions. Concentrations of cytokines/chemokines were determined using ELISA and 35-plex Luminex. * Significantly different at p < 0.05. UT, Untreated; T, Treated.CC BY · PubMed Central
FIGURE 3 (A) Comparison of the effect of treatment with the activating mixture for 72 h on the expression of genes involved in fibrosis in LX-2 cells in mono, di, and tricultures. (B) Effect of treatment with the activating mixture for 72 h on collagen I protein (a key marker of fibrosis) in LX-2 cells in mono, di, and triculture setting. * Significantly different at p < 0.05 with one-way ANOVA. UT, Untreated; T, Treated.
FIGURE 3 (A) Comparison of the effect of treatment with the activating mixture for 72 h on the expression of genes involved in fibrosis in LX-2 cells in mono, di, and tricultures. (B) Effect of treatment with the activating mixture for 72 h on collagen I protein (a key marker of fibrosis) in LX-2 cells in mono, di, and triculture setting. * Significantly different at p < 0.05 with one-way ANOVA. UT, Untreated; T, Treated.CC BY · PubMed Central
FIGURE 4 Protective effect of 5 µM berberine on intracellular lipid accumulation and ROS in HepG2 hepatocytes in the tricultures exposed to the activating mixture for 72 h. (A) Representative fluorescence images with a ×20 objective lens using Nile Red fluorescence probe showing intracellular lipid content. (B) Intracellular lipids in HepG2 hepatocytes in the triculture setting after quantification of Nile Red fluorescence using a microplate reader. Nile Red fluorescence was normalized to Hoechst fluorescence to control for cell proliferation. (C) Intracellular ROS in HepG2 cells in the triculture setting after quantification of DCFH-DA fluorescence using a microplate reader. DCFH-DA fluorescence was normalized to Hoechst fluorescence. Untreated was set at 100% and data are presented as % of the untreated cells. * Significantly different at p < 0.05 with one-way ANOVA. UT, Untreated; T, Treated; Ber, Berberine.
FIGURE 4 Protective effect of 5 µM berberine on intracellular lipid accumulation and ROS in HepG2 hepatocytes in the tricultures exposed to the activating mixture for 72 h. (A) Representative fluorescence images with a ×20 objective lens using Nile Red fluorescence probe showing intracellular lipid content. (B) Intracellular lipids in HepG2 hepatocytes in the triculture setting after quantification of Nile Red fluorescence using a microplate reader. Nile Red fluorescence was normalized to Hoechst fluorescence to control for cell proliferation. (C) Intracellular ROS in HepG2 cells in the triculture setting after quantification of DCFH-DA fluorescence using a microplate reader. DCFH-DA fluorescence was normalized to Hoechst fluorescence. Untreated was set at 100% and data are presented as % of the untreated cells. * Significantly different at p < 0.05 with one-way ANOVA. UT, Untreated; T, Treated; Ber, Berberine.CC BY · PubMed Central
FIGURE 5 Effect of treatment with the activating mixture and 5 µM berberine for 72 h on pro-inflammatory cytokines and chemokines in culture media from tricultures. Concentrations of cytokines and chemokines were measured with 35-plex Luminex, except for IL-8 and IL-6, which were measured with ELISA. * Significantly different at p < 0.05 with one-way ANOVA. UT, Untreated; T, Treated; Ber, Berberine.
FIGURE 5 Effect of treatment with the activating mixture and 5 µM berberine for 72 h on pro-inflammatory cytokines and chemokines in culture media from tricultures. Concentrations of cytokines and chemokines were measured with 35-plex Luminex, except for IL-8 and IL-6, which were measured with ELISA. * Significantly different at p < 0.05 with one-way ANOVA. UT, Untreated; T, Treated; Ber, Berberine.CC BY · PubMed Central
FIGURE 6 Berberine reduces activating mixture-induced collagen I protein levels in LX-2 cells in tricultures after 72 h * Significantly different at p < 0.05 with one-way ANOVA. UT, Untreated; T, Treated; Ber, Berberine.
FIGURE 6 Berberine reduces activating mixture-induced collagen I protein levels in LX-2 cells in tricultures after 72 h * Significantly different at p < 0.05 with one-way ANOVA. UT, Untreated; T, Treated; Ber, Berberine.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 55 references

Cited by

See all 21

Metadata

Authors
Rafiei, H., Yeung, M., Kowalski, S., Krystal, G., & Elisia, I.
Affiliations
BC Cancer Agency (CA)
Corresponding author
Elisia, Ingrid
Venue
Frontiers in Pharmacology
Published
2023-10-19
Volume
14
Pages
1234300-1234300
ISSN
1663-9812 (ISSN-L)
OpenAlex
W4387779215
Cited by
21
References
55
Citations by year
2026: 8 · 2025: 5 · 2024: 8
FWCI
4.18
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Pharmacology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Lotte and John Hecht Memorial Foundation (3693)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Medicine › Pharmacology (medical) › Berberine and alkaloids research
Keywords
non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, berberine, steatosis, oxidative stress, liver fibrosis, hepatic stellate cells, THP-1 macrophages, HepG2 cells, inflammatory cytokines, high-throughput drug screening, collagen synthesis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Development of a novel human triculture model of non-alcoholic fatty liver disease and identification of berberine as ameliorating steatosis, oxidative stress and fibrosis. https://app.cochat.ai/papers/10.3389/fphar.2023.1234300
The paper
Rafiei, H., Yeung, M., Kowalski, S., Krystal, G., & Elisia, I. (2023). Development of a novel human triculture model of non-alcoholic fatty liver disease and identification of berberine as ameliorating steatosis, oxidative stress and fibrosis. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2023.1234300

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.